Title: Korea is where cheap screens go to die: research-process note, not a stock pitch

I wrote up a research-process piece on Korean equities and a failure mode I keep seeing in stock-research agents: they can summarize statistically cheap stocks, but they often do not delete weak ideas before inventing a thesis.

Korea is a good stress test because low P/B, net cash, Value-Up, defense, nuclear, robotics, and holdco screens can all look attractive. The edge, if there is one, starts when names are removed for ticker/entity mismatch, weak liquidity, trapped cash, related-party economics, weak minority-shareholder path, or catalysts that do not reach actual revenue/profit/cash flow.

Core survivor stack from the public note: Poongsan, BHI, Woojin.

Separate moonshot drawer for further research prompts: Innospace, Mobiis, CellBion, IntoCell, SBB Tech.

Agent-readable benchmark: https://barneywohl.github.io/korea-research-map-agents/

GitHub repo: https://github.com/barneywohl/korea-research-map-agents

Full article: https://barneywohl.substack.com/p/the-korea-research-map-where-cheap?r=7xa6e3

Research commentary only. Not investment advice. I am sharing this as a process / source-discipline benchmark, not as a recommendation list.